Whole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast Cancer - A Feasibility Study.
Bernadette Anna Sophia JaegerNatalia KrawczykAnna Sophia JappEllen HonischKarl KöhrerSibylle ScheuringPatrick PetzschHans NeubauerAnne Kathrin VolkmerIrene EspositoEugen RuckhäberleDieter NiederacherTanja FehmPublished in: Geburtshilfe und Frauenheilkunde (2023)
Resulting treatment options were discussed in a tumor board and could be recommended in a small but relevant proportion of patients with metastatic breast cancer (7/18). Thus, this study is a valuable preliminary work for the establishment of a molecular tumor board within the German initiative "Center for Personalized Medicine" which aims to shorten time for analyses and optimize selection of targeted therapies.